Dr David Handojo Muljono

Professor Muljono is a clinician, who also works in the arena of basic biomedical research. He joined the Eijkman Institute for Molecular Biology in Jakarta in 1995 as the head of the hepatitis unit, and has been carrying out basic and translational researches in viral hepatitis. In 2014, he was appointed as the Deputy Director for Translational Research of the Eijkman Institute.

He was graduated as a medical doctor and had a specialist training in Internal Medicine at Airlangga University, Indonesia, and in Hepatology at University of Sydney, Australia, and obtained PhD at Jichi Medical School, Japan. In his academic and scientific careers, he has been involved in teaching and supervision in Post-Graduate (Master and PhD) Program in Indonesia and abroad (Australia, Italy, Denmark, and Netherlands).In his scientific career, he has published numerous manuscripts, and has been acting as the Editor and Reviewer in many International Journals. On July 1, 2011, he was awarded the title Academy Professor in Life Science by the Royal Netherlands Academy of Arts and Sciences (KNAW) and the Indonesian Academy of Sciences (AIPI). On November 30, he was assigned as an Endowed Professor at the Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia. He was also awarded the title Honorary Professor from Sydney Medical School since September 2014.In September 2021, he was inaugurated as a permanent member of the AIPI.

He has been actively involved in international and national activities targeted to public health in the prevention and control of viral hepatitis and emerging diseases. In 1989-1992, he was involved in the WHO Project on Universal Infant Hepatitis B Immunization in Lombok Island, Indonesia. In 2010, he was a Delegate of the Indonesia to the World Health Assembly (WHA); in that occasion, Indonesia, together with Brazil and Columbia initiated the WHA Resolution 63.18 on Viral Hepatitis, which was adopted by the Assembly as a Global Health Problem. He was assigned as a member of the Strategic and Technical Advisory Committee in Hepatitis (STAC-Hep) to the Director General of the World Health Organization (WHO) from 2014 to 2016, and involved in the development of the WHO Guidelines on the Control of Hepatitis B in 2015. Currently, Member the Strategic and Technical Advisory Group (STAG) on Viral Hepatitis in WHO South-East Asia Region (May 2020 – Dec 202I). In late 2021 he was accepted as a member of the WHO Expert Committee on Biological Standardization (ECBS).

In his professional activities, he is a member of the Indonesian Association of Medicine (IDI), Indonesian Society of Internal Medicine, and Indonesian Association for the Study of the Liver (Ina-ASL/PPHI), and several International Societies of Liver Diseases including America (AASLD), Europe (EASL), and the Asia-Pacific (APASL). Since 2017, he is assigned as a member of the Executive Committee of APASL. In June 2018, he was awarded with Fellow of AASLD (FAASLD) designation. 

For his services, he has received several awards, including Ronpaku Gold Medal from the Japanese Society for the Promotion of Science (JSPS) for the discovery of Transfusion Transmissible Virus (TTV) in Indonesia (2000), Ksatria Bakti Husada Kartika from the Minister of Health of Indonesia as the highest distinction award in Health (2011), and Satya Lencana Karya Bakti XXX from the President of Indonesia for continuous services to the public (2012).